TACSTD2
Basic information
Region (hg38): 1:58575433-58577252
Previous symbols: [ "M1S1" ]
Links
Phenotypes
GenCC
Source:
- gelatinous drop-like corneal dystrophy (Strong), mode of inheritance: AR
- gelatinous drop-like corneal dystrophy (Supportive), mode of inheritance: AR
- gelatinous drop-like corneal dystrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Corneal dystrophy, gelatinous drop-like | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 10192395; 12614764; 19693293; 20806038; 21541270 |
ClinVar
This is a list of variants' phenotypes submitted to
- Lattice corneal dystrophy Type III (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TACSTD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 23 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 11 | 10 | 23 | |||
Total | 1 | 0 | 36 | 7 | 16 |
Highest pathogenic variant AF is 0.0000197
Variants in TACSTD2
This is a list of pathogenic ClinVar variants found in the TACSTD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-58575434-G-T | Lattice corneal dystrophy Type III | Likely benign (Jan 13, 2018) | ||
1-58575470-T-TA | Corneal Dystrophy, Dominant/Recessive | Uncertain significance (Jun 14, 2016) | ||
1-58575529-A-T | Lattice corneal dystrophy Type III | Uncertain significance (Jan 12, 2018) | ||
1-58575540-A-G | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58575548-C-T | Lattice corneal dystrophy Type III | Benign (Jan 13, 2018) | ||
1-58575620-C-A | Lattice corneal dystrophy Type III | Benign (Jan 13, 2018) | ||
1-58575764-T-C | Lattice corneal dystrophy Type III | Benign (Jan 12, 2018) | ||
1-58575789-A-G | Lattice corneal dystrophy Type III | Likely benign (Jan 13, 2018) | ||
1-58575887-T-G | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58575904-T-G | Lattice corneal dystrophy Type III | Uncertain significance (Jan 12, 2018) | ||
1-58575905-A-G | Lattice corneal dystrophy Type III | Benign (Jan 13, 2018) | ||
1-58575949-G-C | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58575959-G-T | Lattice corneal dystrophy Type III | Benign (Jan 13, 2018) | ||
1-58575983-T-C | Lattice corneal dystrophy Type III | Benign (Jan 12, 2018) | ||
1-58576019-G-A | Lattice corneal dystrophy Type III | Benign (Jan 12, 2018) | ||
1-58576087-G-A | Lattice corneal dystrophy Type III | Likely benign (Jan 12, 2018) | ||
1-58576091-C-T | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58576126-T-G | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58576137-C-T | Lattice corneal dystrophy Type III | Benign (Jan 12, 2018) | ||
1-58576179-G-A | Lattice corneal dystrophy Type III | Uncertain significance (Jan 13, 2018) | ||
1-58576258-C-T | Lattice corneal dystrophy Type III • not specified | Conflicting classifications of pathogenicity (Sep 22, 2022) | ||
1-58576268-T-C | Lattice corneal dystrophy Type III | Benign (Dec 12, 2023) | ||
1-58576286-C-G | not specified | Uncertain significance (Dec 20, 2022) | ||
1-58576298-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
1-58576329-G-A | Lattice corneal dystrophy Type III | Benign (Dec 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TACSTD2 | protein_coding | protein_coding | ENST00000371225 | 1 | 2068 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00466 | 0.698 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.562 | 187 | 210 | 0.891 | 0.0000135 | 2020 |
Missense in Polyphen | 61 | 69.467 | 0.87811 | 705 | ||
Synonymous | 1.99 | 77 | 103 | 0.751 | 0.00000714 | 708 |
Loss of Function | 0.690 | 4 | 5.79 | 0.691 | 2.48e-7 | 68 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a growth factor receptor.;
- Disease
- DISEASE: Corneal dystrophy, gelatinous drop-like (GDLD) [MIM:204870]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. GDLD is an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness. Clinical manifestations, which appear in the first decade of life, include blurred vision, photophobia, and foreign-body sensation. By the third decade, raised, yellowish- gray, gelatinous masses severely impair visual acuity. {ECO:0000269|PubMed:10192395}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.256
Intolerance Scores
- loftool
- 0.617
- rvis_EVS
- 1.08
- rvis_percentile_EVS
- 91.8
Haploinsufficiency Scores
- pHI
- 0.341
- hipred
- N
- hipred_score
- 0.272
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.522
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tacstd2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; neoplasm;
Gene ontology
- Biological process
- cell surface receptor signaling pathway;visual perception;cell population proliferation;negative regulation of epithelial cell migration;regulation of epithelial cell proliferation;negative regulation of stress fiber assembly;ureteric bud morphogenesis;negative regulation of branching involved in ureteric bud morphogenesis;cell-cell adhesion;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of ruffle assembly;negative regulation of cell motility;positive regulation of stem cell differentiation
- Cellular component
- extracellular space;nucleus;cytosol;integral component of plasma membrane;bicellular tight junction;basal plasma membrane;membrane;lateral plasma membrane;extracellular exosome
- Molecular function
- protein binding;signaling receptor activity;cadherin binding involved in cell-cell adhesion